Advertisement

Topics

Bruker Signs Agreement to Acquire Oncovision’s Preclinical PET Imaging Business

06:43 EDT 23 Sep 2016 | Lab Bulletin

PET and SPECT are key technologies for Bruker’s Preclinical Imaging division, allowing Bruker to offer the highest-performance SiPM-PET/SPECT/CT and integrated SiPM-PET/MR imaging systems.

AlbiraSiBruker has announced that it has signed an agreement to acquire the preclinical imaging business of Oncovision, a leading provider of innovative medical imaging devices used for the diagnosis of cancer. Financial terms of the agreement were not disclosed. For the past five years, Bruker and Oncovision have partnered on an exclusive marketing agreement for Albira™ PET/SPECT/CT systems...

Original Article: Bruker Signs Agreement to Acquire Oncovision’s Preclinical PET Imaging Business

NEXT ARTICLE

More From BioPortfolio on "Bruker Signs Agreement to Acquire Oncovision’s Preclinical PET Imaging Business"

Quick Search
Advertisement
 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...